CHARIOT: Development and Internal Validation of a Cardiovascular Health Assessment and Risk-based Intervention Optimisation Tool
Pate, A.; Jiang, B.; Huang, Y.-T.; Griffiths, S.; Stables, D.; McMillan, B.; Sperrin, M.
Show abstract
Cardiovascular disease (CVD) risk prediction models are widely used to guide primary prevention, yet conventional approaches can only tell patients that something should change, not how much specific actions would reduce their risk. Developed using electronic health records from 19,410,403 UK adults, CHARIOT combines survival analysis with causal inference to predict 10-year CVD risk under statin initiation, antihypertensive therapy, smoking cessation, or lifestyle modifications targeting weight, blood pressure and lipids, and is designed for repeated use over clinical encounters. To illustrate its clinical utility: for a 70-year-old woman with 18.97% baseline risk, CHARIOT estimates risk reductions to 14.32% (statins), 15.26% (10mmHg blood pressure reduction), or 15.77% (smoking cessation). Internal validation demonstrated strong calibration across sex, age, ethnicity, and English regions, with discrimination (c-statistic) of 0.874 (female) and 0.859 (male). CHARIOT is publicly available as an interactive application and represents a substantive step toward actionable, patient-centred CVD prevention at scale.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- RESEARCH PROTOCOL: Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus 94%
- Real-world effects of ACE inhibitors and Angiotensin Receptor Blockers: protocol for an emulation study of the ONTARGET trial using electronic health records 93%
- Identifying markers of health-seeking behaviour and healthcare access in UK electronic health records 93%
Similar papers in this journal
- Differences in estimates for ten-year risk of cardiovascular disease in Black versus white persons with identical risk factor profiles using pooled cohort equations 96%
- An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: national validation cohort study in England 94%
- COVID-19 collateral: Indirect acute effects of the pandemic on physical and mental health in the UK 92%
Similar papers in this journal
- Cohort Design and Natural Language Processing to Reduce Bias in Electronic Health Records Research: The Community Care Cohort Project 94%
- Response to Polygenic Risk: Results of the MyGeneRank Mobile Application-Based Coronary Artery Disease Study 93%
- Continuous-Time and Dynamic Suicide Attempt Risk Prediction with Neural Ordinary Differential Equations 92%
Similar papers in this journal
- Natural language processing for scalable feature engineering and ultra-high-dimensional confounding adjustment in healthcare database studies 93%
- A scoping review of fair machine learning techniques when using real-world data 93%
- Automated Interpretable Discovery of Heterogeneous Treatment Effectiveness: A Covid-19 Case Study 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.